Trial intelligence / Profile preview

Miralax/Gatorade vs MoviPrep for Colonoscopy

NCT01695863Phase 4Completed

Sponsor
Rush University Medical Center
Start
Feb 2012
Primary completion
Nov 2012
Modality
Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
Countries
1
01

Overview

A Phase 4 trial of polyethylene glycol 3350 in colorectal cancer (CRC), sponsored by Rush University Medical Center. Started Feb 2012; status: completed.

02

Drugs

polyethylene glycol 3350
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT01695863.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01695863.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call